Cancer doctors at Massachusetts General Hospital plan within a year to read the genetic fingerprints of nearly all new patients' tumors to customize treatment. The goal is to spare patients from the traditional approach to cancer care, when expensive drugs with harmful side effects are often given without knowing whether they will work.